STERIS’s (STE) Overweight Rating Reiterated at Stephens

STERIS (NYSE:STE)‘s stock had its “overweight” rating reiterated by analysts at Stephens in a research note issued to investors on Thursday,Benzinga reports. They currently have a $240.00 price objective on the medical equipment provider’s stock. Stephens’ price target would indicate a potential upside of 7.56% from the company’s previous close.

Several other research analysts have also recently commented on the stock. Piper Sandler increased their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. StockNews.com downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Finally, JMP Securities reissued a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Monday, November 18th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Stock Performance

STE opened at $223.13 on Thursday. The company has a market capitalization of $22.03 billion, a price-to-earnings ratio of 50.94 and a beta of 0.84. The business’s 50-day moving average price is $212.49 and its two-hundred day moving average price is $224.60. STERIS has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 1.55.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.02% and a return on equity of 13.78%. Equities analysts expect that STERIS will post 9.11 EPS for the current fiscal year.

Insider Activity at STERIS

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $217.32, for a total value of $365,532.24. Following the sale, the senior vice president now owns 11,372 shares in the company, valued at $2,471,363.04. This represents a 12.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.14% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in STE. Natural Investments LLC acquired a new position in shares of STERIS in the fourth quarter valued at $334,000. Citizens Financial Group Inc. RI boosted its holdings in shares of STERIS by 5.9% during the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock worth $201,000 after buying an additional 54 shares during the period. Daiwa Securities Group Inc. boosted its holdings in shares of STERIS by 6.6% during the 4th quarter. Daiwa Securities Group Inc. now owns 14,632 shares of the medical equipment provider’s stock worth $3,008,000 after buying an additional 908 shares during the period. Amundi grew its stake in STERIS by 28.1% in the 4th quarter. Amundi now owns 459,066 shares of the medical equipment provider’s stock valued at $96,142,000 after buying an additional 100,740 shares during the last quarter. Finally, Edgestream Partners L.P. bought a new position in STERIS in the 4th quarter valued at about $2,426,000. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.